ArticleCureus2026
Breast Cancer Radiotherapy Plan Metrics: A Principal Component Analysis Using the Mean Absolute Dose Deviation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Radiotherapy for breast cancer must deliver a sufficient dose to the targets while limiting the dose to the heart, lungs, and contralateral breast. Treatment plans are evaluated on many dose-volume metrics at once, and the balance between target coverage and organ sparing depends on the patient's setup and on the radiotherapy technique. We investigate the relationships among doses to targets, organs, and patient and treatment factors, and examine whether principal component analysis (PCA) can display these relationships in a small factorial planning dataset. Methods PCA was applied to the data from a quasi-experimental two-level factorial treatment planning study of breast cancer adjuvant radiotherapy. The quasi-experiment assessed all combinations of five variables in eight patients: tumor laterality (left vs. right), surgery (mastectomy vs. breast-conserving), target volume (with vs. without lymph nodes), patient's setup position (supine vs. prone) (each patient underwent simulation in the two positions), and radiation delivery (conventional radiotherapy vs. tomotherapy) (both plans were computed in each setup position), which resulted in 32 distinct combinations of the variables. Results PCA showed that tumor left laterality and prone setup were associated with higher heart and contralateral breast doses; nodal irradiation and conventional radiotherapy were associated with higher lung doses, whereas post-mastectomy radiation contributed to high doses to both heart and lung. Tomotherapy was associated with reduced lung doses, better target coverage, slightly reduced heart doses, and increased contralateral breast doses. Conclusion PCA on a factorial design identified correlations between treatment factors and dosimetric outcomes with a minimal number of patients, which might be important in exploratory research, reducing the initial burden of accruing patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.